Immunovant, Inc. (IMVT)

31.18 -0.43 (-1.36%) USD  |  NASDAQ  |  Jun 10, 16:00
31.20 +0.02 (+0.08%) After-Hours: 20:00
More

Immunovant EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for IMVT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical EPS Diluted (5 Year Growth) Data

View and export this data back to 2024. Start Trial.
Date Value
March 31, 2026 --
March 31, 2025 --
Date Value
March 31, 2024 --

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Roivant Sciences Ltd. Upgrade
Summit Therapeutics, Inc. Upgrade
Protagonist Therapeutics, Inc. Upgrade
UroGen Pharma Ltd. Upgrade
Cogent Biosciences, Inc. Upgrade